IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)

Endocrine-Related Cancer

Volumn 13, Issue 2, 2006, Pages 593-605

  Rinaldi, S ^a   Peeters, P H M ^b   Berrino, F ^c   Dossus, L ^a   Biessy, C ^a   Olsen, A ^d   Tjonneland, A ^d   Overvad, K ^e   Clavel Chapelon, F ^f   Boutron Ruault, M C ^f   Tehard B ^f   Nagel, G ^g   Linseisen, J ^g   Boeing, H ^h   Lahmann, P H ^h   Trichopoulou, A ⁱ   Trichopoulos, D ⁱ   Koliva, M ⁱ   Palli, D ^j   Panico, S ^k   Tumino, R ^l   Sacerdote, C ^m   Van Gils, C H ^b   Van Noord, P ^b   Grobbee, D E ^b   Bueno De Mesquita, H B ⁿ   Gonzalez, C A ^o   Agudo, A ^o   Chirlaque, M D ^p   Barricarte, A ^q   Larranaga N ^r   Quiros, J R ^s   Bingham, S ^t   Khaw, K T ^u   Key, T ^v   Allen, N E ^v   Lukanova, A ^w   Slimani, N ^a   Saracci, R ^a   Riboli, E ^x   Kaaks, R ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

ⁱ UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^j CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^k UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^l CIVILE M P AREZZO HOSPITAL   (Italy)

^m CPO Piemonte   (Italy)

ⁿ NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^o CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^p DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^q INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^r Basque Government   (Spain)

^s Public Health and Health Planning Directorate   (Spain)

^t UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^u ADDENBROOKE S HOSPITAL   (United Kingdom)

^v UNIVERSITY OF OXFORD   (United Kingdom)

^w NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^x IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RESEARCH; CANCER RISK; CONTRACEPTION; CONTROLLED STUDY; EUROPE; FEMALE; HUMAN; INCIDENCE; MENOPAUSE; MENSTRUAL CYCLE; NUTRITION; QUESTIONNAIRE; STATISTICAL ANALYSIS; TUMOR DIAGNOSIS; WOMEN'S HEALTH;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPE; FEMALE; HUMANS; INCIDENCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; NUTRITION PHYSIOLOGY; RISK FACTORS;

EID: 33745104067     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.01150     Document Type: Article

References (35)

1. Allen NE, Roddam AW, Allen DS, Fentiman IS, Dos SS, I, Peto J, Holly JM & Key TJ 2005 A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. British Journal of Cancer 92 1283-1287.
2. Bingham S & Riboli E 2004 Diet and cancer - the European Prospective Investigation into Cancer and Nutrition. Nature Reviews in Cancer 4 206-215.
3. Bohlke K, Cramer DW, Trichopoulos D & Mantzoros CS 1998 Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9 570-573.
4. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH & Pollak M 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 563-566.
5. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D & Goodwin PJ 1998 Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Research and Treatment 47 111-120.
6. Fletcher O, Gibson L, Johnson N, Altmann DR, Holly JM, Ashworth A, Peto J & Silva IS 2005 Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiology Biomarkers and Prevention 14 2-19.
7. Giovannucci E, Pollak M, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE & Hankinson SE 2000 Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and the risk of colorectal adenoma and cancer in the Nurses' Health Study. Growth Hormone and IGF Research 10 Suppl A S30-S31.
8. Gram I, Norat T, Rinaldi S, Dossus L, Lukanova A, Tehard B, Clavel-Chapelon F, Van Gils CH, Van Noord PA, Peelers PHM et al. Body mass index, waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. International Journal of Obesity In Press.
9. Gronbaek H, Flyvbjerg A, Mellemkjaer L, Tjonneland A, Christensen J, Toft SH & Overvad K 2004 Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. Cancer Epidemiology Biomarkers and Prevention 13 1759-1764.
10. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE & Pollak M 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 1393-1396.
11. Jones JI & Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16 3-34.
12. Kaaks R, Rinaldi S, Lukanova A, Akhmedkhanov A, Zeleniuch-Jacquotte A & Toniolo P 2001 Correspondence re: Giovannucci et al. 2000 A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiology Biomarkers and Prevention 9 345-349.
13. Cancer Epidemiology Biomarkers and Prevention 10 1103-1104.
14. Kaaks R, Lundin E, Rinaldi S, Manjer J, Biessy C, Soderberg S, Lenner P, Janzon L, Riboli E, Berglund G & Hallmans G 2002 Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 13 307-316.
15. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H et al. 2005a Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). Journal of the National Cancer Institute 97 755-765.
16. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen N et al. 2005b Postmenopausal serum androgens, oestrogens and breast cancer risk; the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocrine-Related Cancer 12 1071-1082.
17. Keinan-Boker L, Bueno-de-Mesquita HB, Kaaks R, Van Gils CH, Van Noord PA, Rinaldi S, Riboli E, Seidell JC, Grobbee DE & Peeters PH 2003 Circulating levels of insulin-like growth factor I, its binding proteins -1, -2, -3, C-peptide and risk of postmenopausal breast cancer. International Journal of Cancer 106 90-95.
18. Krajcik RA, Borofsky ND, Massardo S & Orentreich N 2002 Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiology Biomarkers and Prevention 11 1566-1573.
19. London SJ, Yuan JM, Travlos GS, Gao YT, Wilson RE, Ross RK & Yu MC 2002 Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China. Journal of the National Cancer Institute 94 749-754.
20. Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, Hallmans G, Toniolo P & Kaaks R 2004 Prediagnostic levels of C-peptide, IGF-I, IGFBP-1, -2 and -3 and risk of endometrial cancer. International Journal of Cancer 108 262-268.
21. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH & Stampfer MJ 1999 Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. Journal of the National Cancer Institute 91 620-625.
22. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schunemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M & Berrino F 2002 Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiology Biomarkers and Prevention 11 1361-1368.
23. Palmqvist R, Hallmans G, Rinaldi S, Biessy C, Stenling R, Riboli E & Kaaks R 2002 Plasma insulin-like growth factor-I, insulin-like growth factor binding protein-3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 50 642-646.
24. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J & Demaille A 1993 Plasma insulin-like growth factor-I (IGF-I) concentrations in human breast cancer. European Journal of Cancer 29A 492-497.
25. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM & Egger M 2004 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 1346-1353.
26. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J et al. 2002 European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutrition 5 1113-1124.
27. Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, Koenig KL, Dessus L, Riboli E, Stattin P, Lukanova A & Toniolo P 2005 Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiology Biomarkers and Prevention 14 48-52.
28. Sachdev D & Yee D 2001 The IGF system and breast cancer. Endocrine-Related Cancer 8 197-209.
29. Schernhammer ES, Holly JM, Pollak MN & Hankinson SE 2005 Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiology Biomarkers and Prevention 14 699-704.
30. Shi R, Yu H, McLarty J & Glass J 2004 IGF-I and breast cancer: a meta-analysis. International Journal of Cancer 111 418-423.
31. Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH, Egevad L, Riboli E, Hallmans G & Kaaks R 2000 Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. Journal of the National Cancer Institute 92 1910-1917.
32. Sugumar A, Liu YC, Xia Q, Koh YS & Matsuo K 2004 Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. International Journal of Cancer 111 293-297.
33. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, Lukanova A, Shore RE & Zeleniuch-Jacquotte A 2000 Serum insulin-like growth factor-I and breast cancer. International Journal of Cancer 88 828-832.
34. Yu H & Rohan T 2000 Role of the insulin-like growth factor family in cancer development and progression. Journal of the National Cancer Institute 92 1472-1489.
35. Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ & Zheng W 2002 Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiology Biomarkers and Prevention 11 705-712.